scorecardresearch
Add as a preferred source on Google
Saturday, January 3, 2026
TopicPharma

Topic: Pharma

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

‘Diabetes capital’ India slated to get world’s 1st once-a-week insulin ‘by 2025’

Danish pharma giant Novo Nordisk's Icodec could be game-changer for diabetics. The drug is nearing regulatory approval in US & EU, says company.

Govt sets deadline for pharma MSMEs to adopt good manufacturing practices. ‘Follow or be penalised’

Health minister concedes implementation of Schedule M of Drugs and Cosmetics Act has been poor. Timeline for adherence to norms for good manufacturing practices began on 1 August.

On Camera

How Gen-Z is changing the violent extremist landscape online

The evolving extremist threat now hinges on young people online, demanding new strategies beyond traditional counter-terror models.

India’s urban co-op banks are turning the page—crisis to cautious revival, one metric at a time

With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.